527 related articles for article (PubMed ID: 35457238)
1. Anti-Inflammatory and Neuroprotective Mechanisms of GTS-21, an α7 Nicotinic Acetylcholine Receptor Agonist, in Neuroinflammation and Parkinson's Disease Mouse Models.
Park JE; Leem YH; Park JS; Kim DY; Kang JL; Kim HS
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457238
[TBL] [Abstract][Full Text] [Related]
2. GTS-21 attenuates lipopolysaccharide-induced inflammatory cytokine production in vitro by modulating the Akt and NF-κB signaling pathway through the α7 nicotinic acetylcholine receptor.
Yue Y; Liu R; Cheng W; Hu Y; Li J; Pan X; Peng J; Zhang P
Int Immunopharmacol; 2015 Dec; 29(2):504-512. PubMed ID: 26490221
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory effects of astroglial α7 nicotinic acetylcholine receptors are mediated by inhibition of the NF-κB pathway and activation of the Nrf2 pathway.
Patel H; McIntire J; Ryan S; Dunah A; Loring R
J Neuroinflammation; 2017 Sep; 14(1):192. PubMed ID: 28950908
[TBL] [Abstract][Full Text] [Related]
4. The phosphodiesterase 10 inhibitor papaverine exerts anti-inflammatory and neuroprotective effects via the PKA signaling pathway in neuroinflammation and Parkinson's disease mouse models.
Lee YY; Park JS; Leem YH; Park JE; Kim DY; Choi YH; Park EM; Kang JL; Kim HS
J Neuroinflammation; 2019 Dec; 16(1):246. PubMed ID: 31791357
[TBL] [Abstract][Full Text] [Related]
5. RIPK1 Regulates Microglial Activation in Lipopolysaccharide-Induced Neuroinflammation and MPTP-Induced Parkinson's Disease Mouse Models.
Kim DY; Leem YH; Park JS; Park JE; Park JM; Kang JL; Kim HS
Cells; 2023 Jan; 12(3):. PubMed ID: 36766759
[TBL] [Abstract][Full Text] [Related]
6. GTS-21 has cell-specific anti-inflammatory effects independent of α7 nicotinic acetylcholine receptors.
Garg BK; Loring RH
PLoS One; 2019; 14(4):e0214942. PubMed ID: 30947238
[TBL] [Abstract][Full Text] [Related]
7. Acorus gramineus inhibits microglia mediated neuroinflammation and prevents neurotoxicity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced mouse model of Parkinson's disease.
Jiang J; Kim JJ; Kim DY; Kim MK; Oh NH; Koppula S; Park PJ; Choi DK; Shin YK; Kim IH; Kang TB; Lee KH
J Ethnopharmacol; 2012 Dec; 144(3):506-13. PubMed ID: 23085397
[TBL] [Abstract][Full Text] [Related]
8. Wuzi Yanzong Pill relieves MPTP-induced motor dysfunction and neuron loss by inhibiting NLRP3 inflammasome-mediated neuroinflammation.
Pan T; Xiao Q; Fan HJ; Xu L; Qin SC; Yang LX; Jin XM; Xiao BG; Zhang B; Ma CG; Chai Z
Metab Brain Dis; 2023 Oct; 38(7):2211-2222. PubMed ID: 37470879
[TBL] [Abstract][Full Text] [Related]
9. The role of dorsal root ganglia alpha-7 nicotinic acetylcholine receptor in complete Freund's adjuvant-induced chronic inflammatory pain.
Zhang X; Xu F; Wang L; Li J; Zhang J; Huang L
Inflammopharmacology; 2021 Oct; 29(5):1487-1501. PubMed ID: 34514543
[TBL] [Abstract][Full Text] [Related]
10. Baohuoside I suppresses the NLRP3 inflammasome activation via targeting GPER to fight against Parkinson's disease.
Gu Y; Hu ZF; Zheng DW; Yang YQ; Dong XL; Chen WF
Phytomedicine; 2024 Apr; 126():155435. PubMed ID: 38394727
[TBL] [Abstract][Full Text] [Related]
11. The α7 nicotinic acetylcholine receptor ligands methyllycaconitine, NS6740 and GTS-21 reduce lipopolysaccharide-induced TNF-α release from microglia.
Thomsen MS; Mikkelsen JD
J Neuroimmunol; 2012 Oct; 251(1-2):65-72. PubMed ID: 22884467
[TBL] [Abstract][Full Text] [Related]
12. Attenuation of neuroinflammatory responses and behavioral deficits by Ligusticum officinale (Makino) Kitag in stimulated microglia and MPTP-induced mouse model of Parkinson's disease.
Kim BW; Koppula S; Park SY; Kim YS; Park PJ; Lim JH; Kim IS; Choi DK
J Ethnopharmacol; 2015 Apr; 164():388-97. PubMed ID: 25449453
[TBL] [Abstract][Full Text] [Related]
13. Rubusoside mitigates neuroinflammation and cellular apoptosis in Parkinson's disease, and alters gut microbiota and metabolite composition.
Meng T; Zhang Y; Huang J; Pandey V; Fu S; Ma S
Phytomedicine; 2024 Feb; 124():155309. PubMed ID: 38237261
[TBL] [Abstract][Full Text] [Related]
14. α7 nicotinic acetylcholine receptor-mediated neuroprotection against dopaminergic neuron loss in an MPTP mouse model via inhibition of astrocyte activation.
Liu Y; Hu J; Wu J; Zhu C; Hui Y; Han Y; Huang Z; Ellsworth K; Fan W
J Neuroinflammation; 2012 May; 9():98. PubMed ID: 22624500
[TBL] [Abstract][Full Text] [Related]
15. Imperatorin inhibits oxidative stress injury and neuroinflammation via the PI3K/AKT signaling pathway in the MPTP-induced Parkinson's disease mouse.
Liu L; Jiang L; Zhang J; Ma Y; Wan M; Hu X; Yang L
Neuroreport; 2024 Feb; 35(3):175-184. PubMed ID: 38305108
[TBL] [Abstract][Full Text] [Related]
16. 3-[(2,4-Dimethoxy)benzylidene]-anabaseine dihydrochloride protects against 6-hydroxydopamine-induced parkinsonian neurodegeneration through α7 nicotinic acetylcholine receptor stimulation in rats.
Suzuki S; Kawamata J; Matsushita T; Matsumura A; Hisahara S; Takata K; Kitamura Y; Kem W; Shimohama S
J Neurosci Res; 2013 Mar; 91(3):462-71. PubMed ID: 23239187
[TBL] [Abstract][Full Text] [Related]
17. Wnt/β-catenin signaling plays an essential role in α7 nicotinic receptor-mediated neuroprotection of dopaminergic neurons in a mouse Parkinson's disease model.
Liu Y; Hao S; Yang B; Fan Y; Qin X; Chen Y; Hu J
Biochem Pharmacol; 2017 Sep; 140():115-123. PubMed ID: 28551099
[TBL] [Abstract][Full Text] [Related]
18. Monocytes primed with GTS-21/α7 nAChR (nicotinic acetylcholine receptor) agonist develop anti-inflammatory memory.
Yang X; Zhao C; Chen X; Jiang L; Su X
QJM; 2017 Jul; 110(7):437-445. PubMed ID: 28082382
[TBL] [Abstract][Full Text] [Related]
19. Tanshinone I selectively suppresses pro-inflammatory genes expression in activated microglia and prevents nigrostriatal dopaminergic neurodegeneration in a mouse model of Parkinson's disease.
Wang S; Jing H; Yang H; Liu Z; Guo H; Chai L; Hu L
J Ethnopharmacol; 2015 Apr; 164():247-55. PubMed ID: 25666429
[TBL] [Abstract][Full Text] [Related]
20. The Potent PDE10A Inhibitor MP-10 (PF-2545920) Suppresses Microglial Activation in LPS-Induced Neuroinflammation and MPTP-Induced Parkinson's Disease Mouse Models.
Kim DY; Park JS; Leem YH; Park JE; Kim HS
J Neuroimmune Pharmacol; 2021 Jun; 16(2):470-482. PubMed ID: 32671618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
